Despite progress in the treatment of tumors, resistance to chemotherapy drugs and inter-individual differences in sensitivity to drug treatment remain a substantial obstacle to the healing of many patients. TICheP project aims to develop an innovative technological framework for the development of a personalized chemotherapy allowing reduced toxicity treatment. It will use ovarian carcinoma as a model, but it has the potential for extension to other types of tumors.
Project co-funded by the Regional Operational Program (POR) FESR 2014-2020 “Investimenti a favore della crescita e dell’occupazione” – Activity 1.3.b – DGR No. 1489/2017. Total eligible project expenditure: €1,185,420.00 – Total funded project contribution: €862,037.00. Operation start date 05/11/2018. Operation end date 05/02/2022 (updated figure).